Both in Pharmaceuticals
Dianthus Therapeutics vs Travere Therapeutics
Over the past year DNTH returned +158.5% and TVTX returned +53.6%; their daily moves had a correlation of 0.32.
DNTH +158.5% TVTX +53.6%Growth of $1, one year, split-adjusted
| Metric | DNTH | TVTX |
|---|---|---|
| Price | $85.81 | $52.42 |
| Market cap | $4.80B | $4.94B |
| Today | +3.76% | +6.09% |
| 1 month | +0.5% | −6.4% |
| 6 months | −5.1% | +17.1% |
| Year to date | +108.2% | +37.2% |
| 1 year | +152.2% | +51.8% |
| Revenue growth (YoY) | +294.3% | +36.2% |
| Gross margin | 100.0% | 98.7% |
| Net margin | −6598.6% | −23.3% |
| P/E (TTM) | — | — |
| Price / sales | 2,520.9× | 7.6× |
| Net cash | $886.8M | -$131.7M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 37.8% |
| Short % of float | 18.4% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).